Saturna Capital Corp Novo Nordisk A S Transaction History

Saturna Capital Corp

$7.16 Billion
Q1 2024

A detailed history of Saturna Capital Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Saturna Capital Corp holds 2,139,691 shares of NVO stock, worth $305 Million. This represents 3.84% of its overall portfolio holdings.

Number of Shares

2,139,691

Previous 2,126,774 0.61%

Holding current value

$305 Million

Previous $220 Million 24.87%

% of portfolio

3.84%

Previous 3.47%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $1.32 Million - $1.76 Million	12,917 Added 0.61%	2,139,691 $275 Million
Q4 2023 Feb 06, 2024	SELL	$87.78 - $105.45 $197,505 - $237,262	-2,250 Reduced 0.11%	2,126,774 $220 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $96.6 Million - $212 Million	1,061,862 Added 99.5%	2,129,024 $194 Million
Q2 2023 Aug 04, 2023	SELL	$155.98 - $172.65 $175,477 - $194,231	-1,125 Reduced 0.11%	1,067,162 $173 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $49,627 - $59,677	-375 Reduced 0.04%	1,068,287 $170 Million

Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $298,317 - $393,674	-2,909 Reduced 0.27%	1,068,662 $145 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $25,249 - $30,986	265 Added 0.02%	1,071,571 $107 Million
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $253,970 - $299,652	-2,460 Reduced 0.23%	1,071,306 $119 Million
Q1 2022 May 10, 2022	SELL	$93.1 - $112.54 $186,200 - $225,080	-2,000 Reduced 0.19%	1,073,766 $119 Million
Q4 2021 Feb 09, 2022	BUY	$95.88 - $117.08 $448,047 - $547,114	4,673 Added 0.44%	1,075,766 $120 Million
Q3 2021 Nov 08, 2021	SELL	$84.42 - $106.62 $689,711 - $871,085	-8,170 Reduced 0.76%	1,071,093 $110 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $145,469 - $182,234	2,150 Added 0.2%	1,079,263 $90.4 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $331,947 - $375,308	4,950 Added 0.46%	1,077,113 $72.6 Million
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $75,070 - $86,715	1,175 Added 0.11%	1,072,163 $74.9 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $42,387 - $55,516	857 Added 0.08%	1,070,988 $68.5 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $71,349 - $83,370	1,431 Added 0.13%	1,070,131 $61.9 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $79,486 - $89,334	1,672 Added 0.16%	1,068,700 $55.3 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $27,166 - $30,841	-586 Reduced 0.05%	1,067,028 $55.8 Million
Q4 2018 Feb 08, 2019	BUY	$41.54 - $47.25 $18,693 - $21,262	450 Added 0.04%	1,067,614 $49.2 Million
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $60,788 - $66,612	-1,300 Reduced 0.12%	1,067,164 $50.3 Million
Q1 2018 May 10, 2018	BUY	$48.49 - $58.14 $7,855 - $9,418	162 Added 0.02%	1,068,464 $52.6 Million
Q4 2017 Feb 06, 2018	BUY	$47.53 - $53.73 $9,506 - $10,746	200 Added 0.02%	1,068,302 $57.3 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $87,155 - $104,247	2,118 Added 0.2%	1,068,102 $51.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,065,984	1,065,984 $45.7 Million

Others Institutions Holding NVO

# of Institutions

1,861

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $321B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Novo Nordisk A S Transaction History